Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

N-(Phosphonoacetyl)-L-Ornithine

Generic Name: N-(Phosphonoacetyl)-L-Ornithine

Drug Type: Small Molecule

Chemical Formula: C_₇H_₁₅N_₂O_₆P

CAS Number: 63446-55-9

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS

Phase 2

Completed

Posted: 2011/09/27

Sponsor:

Air Force Military M...

ID:NCT01440829

Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.

Phase 4

Completed

Posted: 2010/01/01

Sponsor:

Centro Regional para...

ID:NCT01041755

Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy

Phase 4

Posted: 2009/05/12

Sponsor:Hospital de Clinicas...

ID:NCT00896831

Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy

Phase 4

Completed

Posted: 2008/08/22

Sponsor:Mahidol University

ID:NCT00740142

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

HEPA-MERZ INFUSION CONCENTRATE 5G/10 ML

Manufacturer:B. Braun Melsungen AG

Form:INFUSION, SOLUTION CONCENTRATE

Strength:5g

Online:Yes

Approved: 2018/11/09

Approval:SIN15578P

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy